Order Article Reprints

Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH. Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma. International Journal of Molecular Sciences. 2023; 24(15):12476. https://doi.org/10.3390/ijms241512476

Ge, Fangfang, Yulu Wang, Amit Sharma, Yu Yang, Hongde Liu, Markus Essler, Ulrich Jaehde, and Ingo G. H. Schmidt-Wolf. 2023. "Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma" International Journal of Molecular Sciences 24, no. 15: 12476. https://doi.org/10.3390/ijms241512476

Ge, F., Wang, Y., Sharma, A., Yang, Y., Liu, H., Essler, M., Jaehde, U., & Schmidt-Wolf, I. G. H. (2023). Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma. International Journal of Molecular Sciences, 24(15), 12476. https://doi.org/10.3390/ijms241512476